Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-717-5 | CAS number: 77538-19-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 Dec 1996 - 10 Jan 1997
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented study report which meets basic scientific principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- study with volunteers
- Principles of method if other than guideline:
- Human Repeat Insult Patch Test with 93 volunteers
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Docosanoic acid, ester with 1,2,3-propanetriol
- EC Number:
- 278-717-5
- EC Name:
- Docosanoic acid, ester with 1,2,3-propanetriol
- Cas Number:
- 77538-19-3
- Molecular formula:
- C25H50O4
- IUPAC Name:
- Docosanoic acid, ester with 1,2,3-propanetriol
- Details on test material:
- - Name of test material (as cited in study report): Behenate de Glycerol
- Physical state: off-white pellets
- Analytical purity: no data
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- confirmed, but no further information available
- Remarks:
- Legally valid written consent, in conformity with: 21 CFR Part 50: "Protection of Human Subjects" was secured from each subject.
- Subjects:
- - Number of subjects exposed: 107 empaneled, 93 completed
- Sex: male and female
- Age: 18-58 years (males), 18-67 years (females)
- Other: No subject was used if he/she exhibited or had a history of any dermatological or other medical or physical condition which could preclude topical application of the test material. No known pregnant or nursing women were used on this study.
A period of at least 6 weeks had elapsed since a subject was patched in a Repeated Insult Patch Test (RIPT) or Photoallergy Test (PA) before he/she was used on this RIPT study. - Controls:
- None
- Route of administration:
- dermal
- Details on study design:
- TYPE OF TEST(S) USED: patch test (epicutaneous test)
ADMINISTRATION
- Type of application: occlusive
- Description of patch: a webril/adhesive patch (Professional Medical Products #4022) was used.
- Vehicle / solvent: unchanged
- Amount applied: approx. 0.2 g (previously molten at 70-80 °C)
- Application site: the left scapular area was the test area for the induction phase. The subject's skin was marked with a gentian violet surgical skin marker at the left side of the test site. The test site was recorded on the anatomical diagram on the back of each subject's individual data form.
- Testing/scoring schedule:
-- Induction: a series of nine (9) induction patchings were completed over a period of three weeks on Mondays, Wednesdays and Fridays.
If a subject was unable to make up a missed patching during the same week, the subject was patched four days the following week (Monday, Tuesday, Thursday and Friday) or was repatched at the end of the induction phase (tenth test day). Any absences and repatchings were noted. Additional absences necessitated dropping the subject from the panel.
Each subject was instructed that the patch was to remain in place and kept dry for approx. 24 h, at which time the patch was to be removed by the subject. A 24 h period, during which no test material was applied, followed the removal of the Monday and Wednesday patch applications; a 48 h period followed the Friday patch applications.
Each subject returned to the testing laboratory on the appropriate day. The test site was observed by the testing laboratory's project manager, and the reaction scored and recorded.
The identical test site was then repatched until the nine induction patchings were completed.
-- Rest period: a rest period of approx. two weeks followed the last induction patching; no test material was applied during the rest period.
-- Challenge Phase: at the challenge phase, the original induction test site was observed and each subject queried as to whether any reaction was experienced during the rest period. The right scapular area was the virgin test site for the challenge phase. The challenge test site was recorded on the anatomical diagram on the back of each subject's individual data form.
The challenge patch was applied to the virgin site only. Each subject was again instructed to keep the patch on and dry.
Each subject reported to the testing laboratory approx. 24 h later, at which time the patch was removed and the challenge site scored by the testing laboratory's project manager. The original test site was also observed.
Each subject reported to the testing laboratory at approx. 48, 72 and 96 h post-patching for additional observations; reactions were scored and recorded.
EXAMINATIONS
- Grading/Scoring system: modified scoring scale of the International Contact Dermatitis Research Group System: Fisher, Alexander A., Contact Dermatitis, Lea & Febiger, Philadelphia, 1986: p. 26 (see Table 1 for details).
Results and discussion
- Results of examinations:
- NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION
- Number of subjects with positive reactions: 0
- Number of subjects with negative reactions: 93 (26 males, 67 females)
- Number of subjects with equivocal reactions: 0
- Number of subjects with irritating reactions: 0
Any other information on results incl. tables
Induction Phase
Three female subjects received 9 induction patchings but were unable to return to the testing facility for the final induction reading; they were therefore given a reading of N9R (No Ninth Reading).
Challenge Phase
A female subject was repatched at 24 h because her challenge patches had fallen off during the evening. The same subject missed the 96 h challenge visit; she returned to the testing facility at 144 h and her site was negative. A verbal report from the subject stated "no reaction at 96 h".
Applicant's summary and conclusion
- Conclusions:
- Not sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.